Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Indivior ( (INDV) ) has issued an announcement.
Indivior PLC has been included in the U.S. Russell 2000® and 3000® Indexes, reflecting its growing presence in the U.S. market, where 85% of its net revenue was generated in 2024, primarily from its SUBLOCADE® medication for opioid use disorder. This inclusion is expected to enhance Indivior’s visibility among investment managers and institutional investors, aligning with its strategy to expand its U.S. business and increase stakeholder value.
More about Indivior
Indivior is a global pharmaceutical company focused on developing medicines to treat opioid use disorder (OUD). Headquartered in Richmond, VA, the company aims to transform OUD from a global crisis to a recognized and treated chronic disease. Indivior’s products are available in over 30 countries, and it employs over 1,000 individuals worldwide.
See more insights into INDV stock on TipRanks’ Stock Analysis page.